These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29986452)

  • 1. Design, Synthesis and Characterization of Novel Co-Polymers Decorated with Peptides for the Selective Nanoparticle Transport across the Cerebral Endothelium.
    Falanga AP; Melone P; Cagliani R; Borbone N; D'Errico S; Piccialli G; Netti PA; Guarnieri D
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29986452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
    Li J; Feng L; Fan L; Zha Y; Guo L; Zhang Q; Chen J; Pang Z; Wang Y; Jiang X; Yang VC; Wen L
    Biomaterials; 2011 Jul; 32(21):4943-50. PubMed ID: 21470674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and degradation behavior of PELGE nanoparticles].
    Duan Y; Zhang Z; Tang Y; Lin Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):921-5. PubMed ID: 15646333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
    Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
    Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
    Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
    Clark AJ; Davis ME
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
    Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
    Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
    Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
    J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-step process to produce surface-functionalized polymeric nanoparticles.
    Sussman EM; Clarke MB; Shastri VP
    Langmuir; 2007 Nov; 23(24):12275-9. PubMed ID: 17963413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
    Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
    Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.